Life Science

A reversible, cell-permeable inhibitor of Src-family tyrosine kinases that have been mutated, by a single base substitution, to become &#39analog sensitive&#39 (as), as compared to the wild-type kinase inhibits v-Src-as1, with an I338G

A fluorescent DAG analog may be used to study interactions with proteins, utilization by cells and liposomes, and for the development of assays for lipid metabolism.

A fluorescent DAG analog may be used to study interactions with proteins, utilization by cells and liposomes, and for the development of assays for lipid metabolism.

A fluorescent DAG analog may be used to study interactions with proteins, utilization by cells and liposomes, and for the development of assays for lipid metabolism.

A cell permeable inhibitor of kinases that have been mutated, by a single base substitution, to become &#39analog sensitive&#39 (as), as compared to the wild type kinase inhibits v-Src-as1, with an I338G substitution, preferentially over v-Src

A cell permeable inhibitor of kinases that have been mutated, by a single base substitution, to become &#39analog sensitive&#39 (as), as compared to the wild type kinase inhibits v-Src-as1, with an I338G substitution, preferentially over v-Src

A cell permeable inhibitor of kinases that have been mutated, by a single base substitution, to become &#39analog sensitive&#39 (as), as compared to the wild type kinase inhibits v-Src-as1, with an I338G substitution, preferentially over v-Src

A cell permeable inhibitor of kinases that have been mutated, by a single base substitution, to become &#39analog sensitive&#39 (as), as compared to the wild type kinase inhibits v-Src-as1, with an I338G substitution, preferentially over v-Src

A metabolite of a phosphotidylinositol ether lipid analog known to target the pleckstrin homology domain of Akt and to induce apoptosis in cancer cell lines with high levels of endogenous Akt activity.

A metabolite of a phosphotidylinositol ether lipid analog known to target the pleckstrin homology domain of Akt and to induce apoptosis in cancer cell lines with high levels of endogenous Akt activity.

A metabolite of a phosphotidylinositol ether lipid analog known to target the pleckstrin homology domain of Akt and to induce apoptosis in cancer cell lines with high levels of endogenous Akt activity.

A metabolite of a phosphotidylinositol ether lipid analog known to target the pleckstrin homology domain of Akt and to induce apoptosis in cancer cell lines with high levels of endogenous Akt activity.